Related Experiment Video
Updated: Apr 20, 2026
10:38
Large-scale Production of Recombinant RNAs on a Circular Scaffold Using a Viroid-derived System in Escherichia coli
Published on: November 30, 2018
10.2K
Analysis of the biological function of ELDF15 using an antisense recombinant expression vector.
Yan Liu1, Long Wang, Zi-Jun Wang
1Chinese Center for Disease Control and Prevention, Beijing, China
Asian Pacific Journal of Cancer Prevention : APJCP
|November 26, 2014
Summary
ELDF15, a protein homologous to ATIP1, influences cell differentiation and proliferation. Inhibiting ELDF15 in K562 cells reduced proliferation and promoted differentiation, suggesting its role in carcinogenesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- ELDF15, homologous to AT2 receptor-interaction protein 1 (ATIP1), is implicated in crucial cellular processes.
- Understanding ELDF15's function is vital for insights into cell differentiation, proliferation, and carcinogenesis.
Purpose of the Study:
- To investigate the biological role of ELDF15.
- To construct and utilize a recombinant expression vector for antisense ELDF15 to modulate its expression in K562 cells.
Main Methods:
- Construction and transfection of a recombinant expression vector (pXJ41-asELDF15) into K562 cells.
- Quantitative assessment of cell proliferation, ELDF15 expression (RT-PCR), hemoglobin levels (benzidine staining), NBT reduction activity, and colony-forming efficiency (soft agar assay).
Main Results:
- Stable transfection resulted in antisense ELDF15 production (pXJ41-asELDF15).
- K562-pXJ41-asELDF15 cells exhibited inhibited proliferation and reduced ELDF15 expression.
- Increased hemoglobin expression and NBT reduction activity indicated enhanced cell differentiation.
- Colony formation in soft agar was significantly inhibited, suggesting anti-carcinogenic potential.
Conclusions:
- ELDF15 plays a significant role in regulating cell differentiation and proliferation.
- The findings suggest ELDF15's involvement in carcinogenesis, offering potential therapeutic targets.
